Posted 3 Feb. 2023 at 11:38Updated Feb 3. 2023 at 11:41
While France prided itself on its health system, the Covid-19 crisis revealed its weaknesses: hospitals out of breath, saturated intensive care units and caregivers left to their own devices. At the same time, the crisis was felt in the industrial sector. We were discovering the extent of our industrial dependence in terms of health vis-à-vis non-European players.
Over the past year, 2,160 breaks or risk of breaks in the supply of drugs as common as Doliprane, adrenaline or even amoxicillin have been observed, declared to the ANSM. In addition, our territory does not have production sites producing certain new therapies on a large scale, such as mRNA, the essential active ingredient of Covid vaccines, and many others in development.
